Sofosbuvir (CAS 1190307-88-0) Market Report

China Sofosbuvir (CAS 1190307-88-0) Industry Market Research Report 2023-2029

  • POSTDATE：Aug 20, 2023
  • PAGES：162
  • REPORT CODE：GMM1746236
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Sofosbuvir (CAS 1190307-88-0) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Beijing Kawin Technology Share-holding Co

    • Tecoland

    • Hangzhou Longshine Bio-Tech Co

    • NIFTY LABS PVT LTD

    • SMS Pharmaceuticals Limited

    • Manus Aktteva Biopharma LLP

    • Sinobright Pharmaceutical Company Limited

    • Teva Pharmaceutical Industries Ltd

    By Type:

    • Below 98% Purity

    • Above 98% Purity

    By Application:

    • 400mg Tablets

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Sofosbuvir (CAS 1190307-88-0) Market Overview 2018-2029

    • 1.1 China Sofosbuvir (CAS 1190307-88-0) Industry Development Overview

    • 1.2 China Sofosbuvir (CAS 1190307-88-0) Industry Development History

    • 1.3 China Sofosbuvir (CAS 1190307-88-0) Industry Market Size (2018-2029)

    • 1.4 China Sofosbuvir (CAS 1190307-88-0) Market Analysis by Type from Production Side

      • 1.4.1 China Sofosbuvir (CAS 1190307-88-0) Production Volume, Production Value and Growth Rate of Below 98% Purity (2018-2029)

      • 1.4.2 China Sofosbuvir (CAS 1190307-88-0) Production Volume, Production Value and Growth Rate of Above 98% Purity (2018-2029)

    • 1.5 China Sofosbuvir (CAS 1190307-88-0) Market Analysis by Application from Consumption End

      • 1.5.1 China Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate of 400mg Tablets (2018-2029)

      • 1.5.2 China Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Sofosbuvir (CAS 1190307-88-0) Market Analysis by Region

      • 1.6.1 North China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Sofosbuvir (CAS 1190307-88-0) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Sofosbuvir (CAS 1190307-88-0) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Sofosbuvir (CAS 1190307-88-0) Market Status and Competition Analysis in 2023

      • 2.2.3 China Sofosbuvir (CAS 1190307-88-0) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Sofosbuvir (CAS 1190307-88-0) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Sofosbuvir (CAS 1190307-88-0) Industry Development

    Chapter 3 Sofosbuvir (CAS 1190307-88-0)Industry Chain Analysis

    • 3.1 Sofosbuvir (CAS 1190307-88-0) Industry Chain

    • 3.2 Sofosbuvir (CAS 1190307-88-0) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Sofosbuvir (CAS 1190307-88-0) Market

    • 3.3 Sofosbuvir (CAS 1190307-88-0) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Sofosbuvir (CAS 1190307-88-0) Market

    Chapter 4 China Sofosbuvir (CAS 1190307-88-0) Market, by Type

    • 4.1 China Sofosbuvir (CAS 1190307-88-0) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Sofosbuvir (CAS 1190307-88-0) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Sofosbuvir (CAS 1190307-88-0) Production Volume and Growth Rate, by Type

      • 4.5.1 China Sofosbuvir (CAS 1190307-88-0) Production Volume and Growth Rate of Below 98% Purity

      • 4.5.2 China Sofosbuvir (CAS 1190307-88-0) Production Volume and Growth Rate of Above 98% Purity

    Chapter 5 China Sofosbuvir (CAS 1190307-88-0) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Sofosbuvir (CAS 1190307-88-0) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate, by Application

      • 5.5.1 China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate of 400mg Tablets

      • 5.5.2 China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate of Others

    Chapter 6 China Sofosbuvir (CAS 1190307-88-0) Market, by Region

    • 6.1 China Sofosbuvir (CAS 1190307-88-0) Production Volume and Production Value, by Region

    • 6.2 China Sofosbuvir (CAS 1190307-88-0) Sales Volume and Sales Value, by Region

    Chapter 7 North China Sofosbuvir (CAS 1190307-88-0) Market Analysis

    • 7.1 North China Sofosbuvir (CAS 1190307-88-0) Market, by Type

    • 7.2 North China Sofosbuvir (CAS 1190307-88-0) Market, by Application

    Chapter 8 Central China Sofosbuvir (CAS 1190307-88-0) Market Analysis

    • 8.1 Central China Sofosbuvir (CAS 1190307-88-0) Market, by Type

    • 8.2 Central China Sofosbuvir (CAS 1190307-88-0) Market, by Application

    Chapter 9 South China Sofosbuvir (CAS 1190307-88-0) Market Analysis

    • 9.1 South China Sofosbuvir (CAS 1190307-88-0) Market, by Type

    • 9.2 South China Sofosbuvir (CAS 1190307-88-0) Market, by Application

    Chapter 10 East China Sofosbuvir (CAS 1190307-88-0) Market Analysis

    • 10.1 East China Sofosbuvir (CAS 1190307-88-0) Market, by Type

    • 10.2 East China Sofosbuvir (CAS 1190307-88-0) Market, by Application

    Chapter 11 Northeast China Sofosbuvir (CAS 1190307-88-0) Market Analysis

    • 11.1 Northeast China Sofosbuvir (CAS 1190307-88-0) Market, by Type

    • 11.2 Northeast China Sofosbuvir (CAS 1190307-88-0) Market, by Application

    Chapter 12 Southwest China Sofosbuvir (CAS 1190307-88-0) Market Analysis

    • 12.1 Southwest China Sofosbuvir (CAS 1190307-88-0) Market, by Type

    • 12.2 Southwest China Sofosbuvir (CAS 1190307-88-0) Market, by Application

    Chapter 13 Northwest China Sofosbuvir (CAS 1190307-88-0) Market Analysis

    • 13.1 Northwest China Sofosbuvir (CAS 1190307-88-0) Market, by Type

    • 13.2 Northwest China Sofosbuvir (CAS 1190307-88-0) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Beijing Kawin Technology Share-holding Co

        • 14.1.1 Beijing Kawin Technology Share-holding Co Company Profile

        • 14.1.2 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Tecoland

        • 14.2.1 Tecoland Company Profile

        • 14.2.2 Tecoland Sofosbuvir (CAS 1190307-88-0) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Hangzhou Longshine Bio-Tech Co

        • 14.3.1 Hangzhou Longshine Bio-Tech Co Company Profile

        • 14.3.2 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 NIFTY LABS PVT LTD

        • 14.4.1 NIFTY LABS PVT LTD Company Profile

        • 14.4.2 NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 SMS Pharmaceuticals Limited

        • 14.5.1 SMS Pharmaceuticals Limited Company Profile

        • 14.5.2 SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Manus Aktteva Biopharma LLP

        • 14.6.1 Manus Aktteva Biopharma LLP Company Profile

        • 14.6.2 Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Sinobright Pharmaceutical Company Limited

        • 14.7.1 Sinobright Pharmaceutical Company Limited Company Profile

        • 14.7.2 Sinobright Pharmaceutical Company Limited Sofosbuvir (CAS 1190307-88-0) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Teva Pharmaceutical Industries Ltd

        • 14.8.1 Teva Pharmaceutical Industries Ltd Company Profile

        • 14.8.2 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Sofosbuvir (CAS 1190307-88-0) Industry Research Conclusions

    • 15.2 Sofosbuvir (CAS 1190307-88-0) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Sofosbuvir (CAS 1190307-88-0) Industry Market Size (2018-2029)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Production Volume, Production Value and Growth Rate of Below 98% Purity (2018-2029)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Production Volume, Production Value and Growth Rate of Above 98% Purity (2018-2029)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate of 400mg Tablets (2018-2029)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate from 2018-2029

    • Figure Central China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate from 2018-2029

    • Figure South China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate from 2018-2029

    • Figure East China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate from 2018-2029

    • Figure Sofosbuvir (CAS 1190307-88-0) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Sofosbuvir (CAS 1190307-88-0) Market Share by Type in 2018

    • Figure China Sofosbuvir (CAS 1190307-88-0) Market Share by Type in 2023

    • Figure China Sofosbuvir (CAS 1190307-88-0) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Production Volume and Growth Rate of Below 98% Purity (2018-2023)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Production Volume and Growth Rate of Above 98% Purity (2018-2023)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Market Share by Application in 2018

    • Figure China Sofosbuvir (CAS 1190307-88-0) Market Share by Application in 2023

    • Figure China Sofosbuvir (CAS 1190307-88-0) Total Market Size and Growth Rate from Consumption End

    • Figure China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate of 400mg Tablets (2018-2023)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate of Others (2018-2023)

    • Table China Sofosbuvir (CAS 1190307-88-0) Production Volume by Region (2018-2023)

    • Table China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Region (2018-2023)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Region (2018-2023)

    • Table China Sofosbuvir (CAS 1190307-88-0) Production Value by Region (2018-2023)

    • Table China Sofosbuvir (CAS 1190307-88-0) Production Value Share by Region (2018-2023)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Production Value Share by Region (2018-2023)

    • Table China Sofosbuvir (CAS 1190307-88-0) Sales Volume by Region (2018-2023)

    • Table China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Region (2018-2023)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Region (2018-2023)

    • Table China Sofosbuvir (CAS 1190307-88-0) Sales Value by Region (2018-2023)

    • Table China Sofosbuvir (CAS 1190307-88-0) Sales Value Share by Region (2018-2023)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Sales Value Share by Region (2018-2023)

    • Table North China Sofosbuvir (CAS 1190307-88-0) Production Volume by Type (2018-2023)

    • Table North China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Type (2018-2023)

    • Figure North China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Type (2018-2023)

    • Table North China Sofosbuvir (CAS 1190307-88-0) Sales Volume by Application (2018-2023)

    • Table North China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Application (2018-2023)

    • Figure North China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Application (2018-2023)

    • Table Central China Sofosbuvir (CAS 1190307-88-0) Production Volume by Type (2018-2023)

    • Table Central China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Type (2018-2023)

    • Figure Central China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Type (2018-2023)

    • Table Central China Sofosbuvir (CAS 1190307-88-0) Sales Volume by Application (2018-2023)

    • Table Central China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Application (2018-2023)

    • Figure Central China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Application (2018-2023)

    • Table South China Sofosbuvir (CAS 1190307-88-0) Production Volume by Type (2018-2023)

    • Table South China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Type (2018-2023)

    • Figure South China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Type (2018-2023)

    • Table South China Sofosbuvir (CAS 1190307-88-0) Sales Volume by Application (2018-2023)

    • Table South China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Application (2018-2023)

    • Figure South China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Application (2018-2023)

    • Table East China Sofosbuvir (CAS 1190307-88-0) Production Volume by Type (2018-2023)

    • Table East China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Type (2018-2023)

    • Figure East China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Type (2018-2023)

    • Table East China Sofosbuvir (CAS 1190307-88-0) Sales Volume by Application (2018-2023)

    • Table East China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Application (2018-2023)

    • Figure East China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Sofosbuvir (CAS 1190307-88-0) Production Volume by Type (2018-2023)

    • Table Northeast China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Type (2018-2023)

    • Table Northeast China Sofosbuvir (CAS 1190307-88-0) Sales Volume by Application (2018-2023)

    • Table Northeast China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Sofosbuvir (CAS 1190307-88-0) Production Volume by Type (2018-2023)

    • Table Southwest China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Type (2018-2023)

    • Table Southwest China Sofosbuvir (CAS 1190307-88-0) Sales Volume by Application (2018-2023)

    • Table Southwest China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Sofosbuvir (CAS 1190307-88-0) Production Volume by Type (2018-2023)

    • Table Northwest China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Sofosbuvir (CAS 1190307-88-0) Production Volume Share by Type (2018-2023)

    • Table Northwest China Sofosbuvir (CAS 1190307-88-0) Sales Volume by Application (2018-2023)

    • Table Northwest China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share by Application (2018-2023)

    • Table Beijing Kawin Technology Share-holding Co Company Profile

    • Table Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Revenue, Price and Gross (2018-2023)

    • Table Tecoland Company Profile

    • Table Tecoland Sofosbuvir (CAS 1190307-88-0) Revenue, Price and Gross (2018-2023)

    • Table Hangzhou Longshine Bio-Tech Co Company Profile

    • Table Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Revenue, Price and Gross (2018-2023)

    • Table NIFTY LABS PVT LTD Company Profile

    • Table NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Revenue, Price and Gross (2018-2023)

    • Table SMS Pharmaceuticals Limited Company Profile

    • Table SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Revenue, Price and Gross (2018-2023)

    • Table Manus Aktteva Biopharma LLP Company Profile

    • Table Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Revenue, Price and Gross (2018-2023)

    • Table Sinobright Pharmaceutical Company Limited Company Profile

    • Table Sinobright Pharmaceutical Company Limited Sofosbuvir (CAS 1190307-88-0) Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Industries Ltd Company Profile

    • Table Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US